{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:19:44Z","timestamp":1790623184104,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ANR","award":["ANR-10-IBHU-0004 OPeRa"],"award-info":[{"award-number":["ANR-10-IBHU-0004 OPeRa"]}]},{"name":"RHU","award":["ANR-16- RHUS-0009"],"award-info":[{"award-number":["ANR-16- RHUS-0009"]}]},{"name":"Soci\u00e9t\u00e9 Francaise de Cardiologie","award":["Bourse Ren\u00e9 Foudon"],"award-info":[{"award-number":["Bourse Ren\u00e9 Foudon"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Myocardial hemorrhage (IMH) and persistent microvascular obstruction (MVO) are associated with impaired myocardial recovery and adverse clinical outcomes in STEMI patients. However, their relationship with circulating inflammatory biomarkers is unclear in human patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and results<\/jats:title>\n<jats:p>Twenty consecutive patients referred for primary percutaneous coronary intervention of first STEMI were included in a prospective study. Blood sampling was performed at admission, 4, 12, 24, 48 hours, 7 and 30 days after reperfusion for inflammatory biomarker (C reactive protein, fibrinogen, interleukin-6 (IL-6) and neutrophils count) assessment. At seven days, cardiovascular magnetic resonance (CMR) was performed for infarct size, MVO and IMH assessment. Median infarct size was 24.6% Interquartile range (IQR) [12.0\u201343.5] of LV mass and edema was 13.2% IQR [7.7\u201336.1] of LV mass. IL-6 reached a peak at H24 (5.6 pg\/mL interquartile range (IQR) [2.5\u201317.5]), CRP at H48 (11.7 mg\/L IQR [7.1\u201369.2]), fibrinogen one week after admission (4.4 g\/L IQR [3.8\u20136.7]) and neutrophils at H12 (9.0 G\/L IQR [6.5\u201312.7]). MVO was present in 11 patients (55% of the study population) and hemorrhage in 7 patients (35%). Patients with IMH had significantly higher IL-6, CRP, fibrinogen, and neutrophils levels compared to patients without IMH. Patients with persistent MVO had significantly higher CRP, fibrinogen and neutrophils level compared to patients without MVO, but identical IL-6 kinetics.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In human patients with acute myocardial infarction, intramyocardial hemorrhage appears to have a stronger relationship with inflammatory biomarker release compared to persistent MVO. Attenuating myocardial hemorrhage may be a novel target in future adjunctive STEMI treatments.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0245684","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T19:33:06Z","timestamp":1611862386000},"page":"e0245684","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Association of myocardial hemorrhage and persistent microvascular obstruction with circulating inflammatory biomarkers in STEMI patients"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5889-7506","authenticated-orcid":true,"given":"Thomas","family":"Bochaton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Lassus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Paccalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Derimay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Rioufol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Prieur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bonnefoy-Cudraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Crola Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Bernelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4811-3859","authenticated-orcid":true,"given":"Camille","family":"Amaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Espanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"de Bourguignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Dufay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gine","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Croisille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Ovize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Mewton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"pone.0245684.ref001","volume-title":"Global atlas on cardiovascular disease prevention and control","author":"World Health Organization., World Heart Federation., World Stroke Organization","year":"2011"},{"key":"pone.0245684.ref002","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"N Townsend","year":"2016","journal-title":"Eur Heart J"},{"key":"pone.0245684.ref003","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/heartjnl-2013-304517","article-title":"Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003\u20132010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR)","volume":"100","author":"CP Gale","year":"2014","journal-title":"Heart"},{"key":"pone.0245684.ref004","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"DM Yellon","year":"2007","journal-title":"N Engl J Med"},{"key":"pone.0245684.ref005","article-title":"THE PRESENT AND FUTURE Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction","volume":"67","author":"PC Westman","year":"2016","journal-title":"JAC"},{"key":"pone.0245684.ref006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","article-title":"The inflammatory response in myocardial infarction","volume":"53","author":"NG Frangogiannis","year":"2002","journal-title":"Cardiovasc Res"},{"key":"pone.0245684.ref007","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/hrt.47.3.239","article-title":"Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction","volume":"47","author":"FC de Beer","year":"1982","journal-title":"Br Heart J"},{"key":"pone.0245684.ref008","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/eurheartj\/14.7.915","article-title":"Serum c-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy","volume":"14","author":"K Pietil\u00e4","year":"1993","journal-title":"Eur Heart J"},{"key":"pone.0245684.ref009","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0002-9149(99)00162-9","article-title":"C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction","volume":"83","author":"S Tommasi","year":"1999","journal-title":"Am J Cardiol"},{"key":"pone.0245684.ref010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/000331970605700304","article-title":"In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis","volume":"57","author":"A Ziakas","year":"2006","journal-title":"Angiology"},{"key":"pone.0245684.ref011","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1161\/01.CIR.96.12.4204","article-title":"Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"96","author":"H Toss","year":"1997","journal-title":"Circulation"},{"key":"pone.0245684.ref012","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0368-1319(69)80016-5","article-title":"Fibrinogen levels in patients suffering from acute myocardial infarction","volume":"10","author":"JA Hashmi","year":"1969","journal-title":"J Atheroscler Res"},{"key":"pone.0245684.ref013","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjcard.2012.11.012","article-title":"Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"111","author":"JJ Park","year":"2013","journal-title":"Am J Cardiol"},{"key":"pone.0245684.ref014","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/eci.12118","article-title":"Targeting inflammatory pathways in myocardial infarction","volume":"43","author":"P Christia","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"pone.0245684.ref015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrcardio.2016.185","article-title":"Inflammatory processes in cardiovascular disease: a route to targeted therapies","volume":"14","author":"N Ruparelia","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"pone.0245684.ref016","doi-asserted-by":"crossref","first-page":"e004148","DOI":"10.1161\/CIRCIMAGING.115.004148","article-title":"Myocardial Hemorrhage After Acute Reperfused ST-Segment-Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognostic Significance","volume":"9","author":"D Carrick","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"pone.0245684.ref017","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004996","article-title":"Persistent Microvascular Obstruction After Myocardial Infarction Culminates in the Confluence of Ferric Iron Oxide Crystals, Proinflammatory Burden, and Adverse Remodeling","volume":"9.","author":"A Kali","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"pone.0245684.ref018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"B Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"pone.0245684.ref019","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/heartjnl-2013-305253","article-title":"Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction","volume":"100","author":"C Liebetrau","year":"2014","journal-title":"Hear"},{"key":"pone.0245684.ref020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.acvd.2015.09.006","article-title":"The no-reflow phenomenon: State of the art","volume":"108","author":"C Bouleti","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"key":"pone.0245684.ref021","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/eurheartj\/eht100","article-title":"Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage","volume":"34","author":"LFHJ Robbers","year":"2013","journal-title":"Eur Heart J"},{"key":"pone.0245684.ref022","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jcmg.2014.06.012","article-title":"Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis","volume":"7","author":"YS Hamirani","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"pone.0245684.ref023","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ijcard.2012.05.055","article-title":"Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: Influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction","volume":"167","author":"O Husser","year":"2013","journal-title":"Int J Cardiol"},{"key":"pone.0245684.ref024","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/01.CIR.99.4.546","article-title":"Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions","volume":"99","author":"M Gwechenberger","year":"1999","journal-title":"Circulation"},{"key":"pone.0245684.ref025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cardiores.2005.08.017","article-title":"IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes","volume":"69","author":"N SMART","year":"2006","journal-title":"Cardiovasc Res"},{"key":"pone.0245684.ref026","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cardiores.2004.05.011","article-title":"IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2","volume":"64","author":"B Dawn","year":"2004","journal-title":"Cardiovasc Res"},{"key":"pone.0245684.ref027","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ejim.2004.07.013","article-title":"IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure","volume":"15","author":"AS Gabriel","year":"2004","journal-title":"Eur J Intern Med"},{"key":"pone.0245684.ref028","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/clc.4960270712","article-title":"Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction","volume":"27","author":"T Ohtsuka","year":"2004","journal-title":"Clin Cardiol"},{"key":"pone.0245684.ref029","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream to Identify Novel Targets for Atheroprotection","volume":"118","author":"PM Ridker","year":"2016","journal-title":"Circ Res"},{"key":"pone.0245684.ref030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2015.04.010","article-title":"Possible mechanisms of C-reactive protein mediated acute myocardial infarction","volume":"760","author":"PA Fordjour","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"pone.0245684.ref031","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cardiores.2003.10.011","article-title":"Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury","volume":"61","author":"J. Vinten-Johansen","year":"2004","journal-title":"Cardiovasc Res"},{"key":"pone.0245684.ref032","first-page":"333","article-title":"Association of Leukocyte and Neutrophil Counts With Infarct Size, Left Ventricular Function and Outcomes After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction","volume":"103","author":"S Chia","year":"2009"},{"key":"pone.0245684.ref033","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.amjmed.2010.10.023","article-title":"Use of neutrophil count in early diagnosis and risk stratification of AMI","volume":"124","author":"J Meissner","year":"2011","journal-title":"Am J Med"},{"key":"pone.0245684.ref034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"D Davalos","year":"2012","journal-title":"Semin Immunopathol"},{"key":"pone.0245684.ref035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0021-9150(00)00703-6","article-title":"Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction","volume":"157","author":"J De Sutter","year":"2001","journal-title":"Atherosclerosis"},{"key":"pone.0245684.ref036","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/eurheartj\/ehp070","article-title":"C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction","volume":"30","author":"S \u00d8rn","year":"2009","journal-title":"Eur Heart J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0245684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T19:33:20Z","timestamp":1611862400000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0245684"}},"subtitle":[],"editor":[{"given":"Stephane","family":"Germain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0245684","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]}}}